SCHEMBL20152297

SCHEMBL20152297

Cc1c2c3ccccc3n(-c3ccc(-c4ccc(-c5ccccc5)cc4)cc3)c2c(C)c2c3ccccc3n(-c3ccc(-c4ccc(-c5ccccc5)cc4)cc3)c12

nearest known ligand 0.46

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 0.46
KDM4E B2RXH2 2/20 0.46
ATM Q13315 1/20 0.46
AVPR1A P37288 1/20 0.40
KMT2A Q03164 3/20 0.39
IL1R1 P14778 1/20 0.39
HDAC4 P56524 1/20 0.38
MAPT P10636 3/20 0.38
MEN1 O00255 2/20 0.38
ALDH1A1 P00352 2/20 0.38
HTT P42858 1/20 0.38
OXTR P30559 1/20 0.37
HSP90AA1 P07900 1/20 0.36
MAPK8 P45983 1/20 0.36
ESR1 P03372 1/20 0.36
ESR2 Q92731 1/20 0.36
RXFP1 Q9HBX9 1/20 0.35
PGR P06401 1/20 0.35
DHODH Q02127 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20152289 1.00 L3MBTL1 (0.46) L3MBTL1KDM4EATMAVPR1AKMT2A
SCHEMBL20152292 1.00 L3MBTL1 (0.46) L3MBTL1KDM4EATMAVPR1AKMT2A
SCHEMBL20152293 0.93 L3MBTL1 (0.40) L3MBTL1KDM4EATMAVPR1AKMT2A
SCHEMBL20152296 0.91 L3MBTL1 (0.42) L3MBTL1KDM4EATMAVPR1AKMT2A
SCHEMBL20152295 0.89 L3MBTL1 (0.47) L3MBTL1KDM4EATMAVPR1AKMT2A
SCHEMBL20152294 0.88 ATM (0.41) L3MBTL1KDM4EATMAVPR1AKMT2A
SCHEMBL20152298 0.87 KDM4E (0.39) L3MBTL1KDM4EATMAVPR1AKMT2A
SCHEMBL14013699 0.86 L3MBTL1 (0.52) L3MBTL1KDM4EATMAVPR1AKMT2A
SCHEMBL20149397 0.85 AVPR1A (0.41) L3MBTL1KDM4EATMAVPR1AKMT2A
SCHEMBL17123101 0.84 L3MBTL1 (0.50) L3MBTL1KDM4EATMAVPR1AKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180138425-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION (US) 2018-05-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180138425-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES DDT, OCIAD1, OCIAD2 L3MBTL1 430/4885KDM4E 1178/4885ATM 4294/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.